Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=27328333
&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
Curr Opin Rheumatol
2016[Sep]; 28
(5
): 544-9
PMID27328333
show ga
PURPOSE OF REVIEW: The review provides updates on novel risk markers for the
development of pediatric inflammatory uveitis and a severe disease course, on
treatment of refractory disease, and on the measurement of visual outcomes.
RECENT FINDINGS: There are several new genetic markers, biomarkers, and clinical
factors that may influence a child's uveitis disease course. It is important to
identify children at risk for poor visual outcomes and who are refractory to
traditional therapy. Racial disparities have recently been reported. We describe
agents of potential benefit. In addition, we discuss the importance of patient
reported outcomes in this population. SUMMARY: Uveitis can lead to
vision-threatening complications. Timely and aggressive treatment of children
identified to be at risk for a severe uveitis course may lead to improved
outcomes.
free
free
free
